New Agent in the Treatment of Cystinuria: N-acetyl-D-penicillamine.
作者信息
Stokes G S, Potts J T, Lotz M, Bartter F C
出版信息
Br Med J. 1968 Feb 3;1(5587):284-8. doi: 10.1136/bmj.1.5587.284.
Abstract
摘要
相似文献
1
New Agent in the Treatment of Cystinuria: N-acetyl-D-penicillamine.
Br Med J. 1968 Feb 3;1(5587):284-8. doi: 10.1136/bmj.1.5587.284.
2
Some complications observed in the treatment of cystinuria with D-penicillamine and N-acetyl-D-penicillamine.
Postgrad Med J. 1968 Oct:Suppl:8-11.
3
4
The treatment of cystinuria with N-acetyl-D-penicillamine, a comparison with the results of D-penicillamine treatment.
Q J Med. 1971 Jul;40(159):355-70.
5
Mechanisms of action of D-penicillamine and n-acetyl D-penicillamine in the therapy of cystinuria.
Clin Sci. 1968 Dec;35(3):467-77.
6
The use of D-penicillamine in cystinuria: efficacy and untoward reactions.
Yale J Biol Med. 1981 Nov-Dec;54(6):439-46.
7
CYSTINURIA: EFFECT OF D-PENICILLAMINE ON PLASMA AND URINARY CYSTINE CONCENTRATIONS.
Science. 1965 Mar 19;147(3664):1459-60. doi: 10.1126/science.147.3664.1459.
8
FURTHER OBSERVATIONS ON USE OF D-PENICILLAMINE IN CYSTINURIA.
Br Med J. 1964 May 30;1(5395):1411-3. doi: 10.1136/bmj.1.5395.1411.
9
Comparison of 2-mercaptopropionylglycine and D-penicillamine in the treatment of cystinuria.
J Urol. 1986 Jul;136(1):146-9. doi: 10.1016/s0022-5347(17)44760-4.
10
RAPID, SIMPLE METHOD FOR DETERMINING EFFECTIVENESS OF D-PENICILLAMINE THERAPY IN CYSTINURIA.
Br Med J. 1965 Aug 28;2(5460):521. doi: 10.1136/bmj.2.5460.521.
引用本文的文献
1
Synthesis and Characterization of a Sustained Nitric Oxide-Releasing Orthodontic Elastomeric Chain for Antimicrobial Action.
Int J Mol Sci. 2024 Jun 26;25(13):6982. doi: 10.3390/ijms25136982.
2
Achieving Long-Term Biocompatible Silicone via Covalently Immobilized S-Nitroso- N-acetylpenicillamine (SNAP) That Exhibits 4 Months of Sustained Nitric Oxide Release.
ACS Appl Mater Interfaces. 2018 Aug 15;10(32):27316-27325. doi: 10.1021/acsami.8b08647. Epub 2018 Aug 1.
3
Biotemplated Synthesis and Characterization of Mesoporous Nitric Oxide-Releasing Diatomaceous Earth Silica Particles.
ACS Appl Mater Interfaces. 2018 Jan 24;10(3):2291-2301. doi: 10.1021/acsami.7b15967. Epub 2018 Jan 11.
4
Characterization of an S-nitroso-N-acetylpenicillamine-based nitric oxide releasing polymer from a translational perspective.
Int J Polym Mater. 2016;65(15):769-778. doi: 10.1080/00914037.2016.1163570. Epub 2016 Jun 15.
5
Cystine stones treated by surgery and D-penicillamine.
Proc R Soc Med. 1968 Nov;61(11 Part 1):1144-6. doi: 10.1177/003591576806111P137.
6
Effects of therapeutically useful thiols (DL-penicillamine and alpha-mercaptopropionylglycine) on immunoglobulins.
Clin Exp Immunol. 1970 Jul;7(1):85-107.
7
Cystinuria and its treatment: 25 years experience at St. Bartholomew's Hospital.
J Inherit Metab Dis. 1989;12(2):197-209. doi: 10.1007/BF01800726.
8
Environmental contaminants and intestinal function.
Environ Health Perspect. 1979 Dec;33:107-14. doi: 10.1289/ehp.7933107.
9
Dissolution of bilateral staghorn cystine renal calculi.
Arch Dis Child. 1979 Oct;54(10):795-8. doi: 10.1136/adc.54.10.795.
本文引用的文献
1
CYSTINURIA AND CYSTINE LITHIASIS.
Can Med Assoc J. 1934 Sep;31(3):250-5.
2
STONE DISSOLUTION IN VIVO AND CONTROL OF CYSTINURIA WITH D-PENICILLAMINE.
N Engl J Med. 1965 Sep 9;273:578-83. doi: 10.1056/NEJM196509092731102.
3
TREATMENT OF CYSTINURIA.
Br Med J. 1965 Feb 13;1(5432):403-8.
4
PYRIDOXINE DEFICIENCY IN THE RAT PRODUCED BY D-PENICILLAMINE.
Nature. 1964 Sep 26;203:1382-3. doi: 10.1038/2031382b0.
5
PENICILLAMINE THERAPY FOR HEPATOLENTICULAR DEGENERATION.
JAMA. 1964 Sep 7;189:748-54. doi: 10.1001/jama.1964.03070100042008.
6
D-PENICILLAMINE, WITH PARTICULAR RELATION TO WILSON'S DISEASE.
J Chronic Dis. 1964 Apr;17:293-8. doi: 10.1016/0021-9681(64)90071-2.
7
Effect of penicillamine on cystinuria.
Br Med J. 1963 Mar 2;1(5330):588-90. doi: 10.1136/bmj.1.5330.588.
8
Treatment of lead-poisoning with oral penicillamine.
Br Med J. 1963 May 11;1(5340):1270-5. doi: 10.1136/bmj.1.5340.1270.
9
Biochemical and pharmacological properties of the metal-binding agent penicillamine.
Fed Proc. 1961 Sep;20(3)Pt 2:185-8.
10
N-acetyl-DL-penicillamine, a new oral protective agent against the lethal effects of mercuric chloride.
J Pharmacol Exp Ther. 1959 Jun;126(2):131-5.
Zotero 插件